Survival, quality of life and breast cancer

Annals of Oncology

Volumn 12, Issue SUPPL. 3, 2001, Pages

  Mosconi, P ^a   Colozza, M ^b   Laurentiis, M De ^c   Placido, S De ^c   Maltoni, M ^d  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b POLICLINICO MONTELUCE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d Ospedale Pierantoni   (Italy)

Author keywords

Adjuvant treatment; Breast cancer; Metastatic disease; Quality of life; Surgical treatment

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; HORMONE DERIVATIVE; METHOTREXATE; TAMOXIFEN; TAXANE DERIVATIVE;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAMMOGRAPHY; MASTECTOMY; METASTASIS; METHODOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT;

EID: 0035661065     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/12.suppl_3.S15     Document Type: Article

References (36)

1. Assessment of quality of life outcomes
2. Looking beyond survival: Assessment of quality of life in breast cancer patients
3. The problem of quality of life in medicine
4. Standards for validating health measures: Definition and content
5. Outcome of cancer treatment for technology assessment and cancer treatment guidelines
6. Breast conservation is the treatment of choice in small breast cancer: Long-term results of a randomized trial
7. Conservative treatment versus mastectomy in early breast cancer: Patterns of failure with 15 years of follow-up data
8. Reanalysis and results after 12 years of follow-up in a randomized trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer
9. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer
10. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial
11. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis
12. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials
13. Consensus statement: Treatment of early-stage breast cancer
14. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: A review
15. Cancer: Psychosocial aspects
16. Psychosocial outcomes of breast-conserving surgery versus mastectomy: A meta-analytic review
17. Polychemotherapy for early breast cancer: An overview of the randomised trials
18. Tamoxifen for early breast cancer: An overview of the randomised trials
19. Comparison of two Quality-of-Life instruments for cancer patients: The Functional Assessment of Cancer Therapy-General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30
20. Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer
21. Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors
22. Adjuvant Chemotherapy for premenopausal breast cancer: A Meta-analysis using Quality-Adjusted Survival
23. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer
24. Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: Meta-analysis of quality-adjusted survival
25. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer
26. Outcome of patients with metastatic breast carcinoma treated at a private medical oncology clinic
27. Cytotoxic and hormonal treatment for metastatic breast cancer: A systematic review of published randomized trials involving 31,510 women
28. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies
29. A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer
30. Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs. epirubicin measuring quality of life
31. Doxorubicin in advanced breast cancer: Influence of schedule on response, survival and quality of life
32. Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer
33. Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients
34. Health-related quality of life in women with metastatic breast cancer treated with trastuzumab (Herceptin)
35. Do patients with advanced breast cancer benefit from chemotherapy?
36. Third line chemotherapy in patients with metastatic breast cancer: An evaluation of quality of life and cost